From Clinical and Translational Research Center Shanghai East Hospital, Key Laboratory of Arrhythmias, Ministry of Education, Tongji University School of Medicine, China (D.W., Jinhui Peng, D.-n.R., J.C., Y. Zhu, Y.Y., H.Y., E.M., Y.C., Zhongmin Liu, S.L., L.A., W.Z.); Department of Orthopedics, Changzheng Hospital, Shanghai, China (Jinhui Peng, Q.Q.); Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China (L.Q., Jun Peng); Shanghai Key Laboratory of Signaling and Disease Research, The School of Life Sciences and Technology, Tongji University, China (Zhenping Liu, C.J.); State Key Laboratory of Genetic Engineering, Department of Genetics, School of Life Sciences, Fudan University, Shanghai, China (Y.Y., T.Z.); and Institutes of Biomedical Sciences, Fudan University, Shanghai, China (J.W., Y. Zou).
Circulation. 2016 Dec 13;134(24):1991-2007. doi: 10.1161/CIRCULATIONAHA.116.024441. Epub 2016 Nov 1.
Myocardial infarction is one of the leading causes of morbidity and mortality worldwide, triggering irreversible myocardial cell damage and heart failure. The role of low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) as coreceptors of the Wnt/β-catenin pathway in the adult heart remain unknown. Insulin-like growth factor binding protein 4 and dickkopf-related protein 1 (Dkk1) are 2 secreted LRP5/6 binding proteins that play a crucial role in heart development through preventing Wnt/β-catenin pathway activation. However, their roles in the adult heart remain unexplored.
To understand the role of LRP5/6 and β-catenin in the adult heart, we constructed conditional cardiomyocyte-specific LRP5/6 and β-catenin knockout mice and induced surgical myocardial infarction. We also directly injected recombinant proteins of insulin-like growth factor binding protein 4 and Dkk1 into the heart immediately following myocardial infarction to further examine the mechanisms through which these proteins regulate LRP5/6 and β-catenin.
Deletion of LRP5/6 promoted cardiac ischemic insults. Conversely, deficiency of β-catenin, a downstream target of LRP5/6, was beneficial in ischemic injury. It is interesting to note that although both insulin-like growth factor binding protein 4 and Dkk1 are secreted Wnt/β-catenin pathway inhibitors, insulin-like growth factor binding protein 4 protected the ischemic heart by inhibiting β-catenin, whereas Dkk1 enhanced the injury response mainly through inducing LRP5/6 endocytosis and degradation.
Our findings reveal previously unidentified dual roles of LRP5/6 involved in the cardiomyocyte response to ischemic injury. These findings suggest new therapeutic strategies in ischemic heart disease by fine-tuning LRP5/6 and β-catenin signaling within the Wnt/β-catenin pathway.
心肌梗死是全球发病率和死亡率的主要原因之一,会引发心肌细胞不可逆转的损伤和心力衰竭。低密度脂蛋白受体相关蛋白 5 和 6(LRP5/6)作为 Wnt/β-连环蛋白通路在成年心脏中的核心受体的作用尚不清楚。胰岛素样生长因子结合蛋白 4 和 Dickkopf 相关蛋白 1(Dkk1)是 2 种分泌型 LRP5/6 结合蛋白,通过阻止 Wnt/β-连环蛋白通路的激活,在心脏发育中发挥着至关重要的作用。然而,它们在成年心脏中的作用仍未被探索。
为了了解 LRP5/6 和 β-连环蛋白在成年心脏中的作用,我们构建了条件性心肌细胞特异性 LRP5/6 和 β-连环蛋白敲除小鼠,并诱导了手术性心肌梗死。我们还直接在心肌梗死后立即向心脏内注射胰岛素样生长因子结合蛋白 4 和 Dkk1 的重组蛋白,以进一步研究这些蛋白调节 LRP5/6 和 β-连环蛋白的机制。
LRP5/6 的缺失促进了心脏的缺血损伤。相反,LRP5/6 的下游靶点 β-连环蛋白的缺失对缺血损伤有益。有趣的是,尽管胰岛素样生长因子结合蛋白 4 和 Dkk1 都是分泌型 Wnt/β-连环蛋白通路抑制剂,但胰岛素样生长因子结合蛋白 4 通过抑制 β-连环蛋白来保护缺血心脏,而 Dkk1 主要通过诱导 LRP5/6 内吞和降解来增强损伤反应。
我们的研究结果揭示了 LRP5/6 在心肌细胞对缺血损伤反应中的先前未被识别的双重作用。这些发现为通过精细调节 Wnt/β-连环蛋白通路中的 LRP5/6 和 β-连环蛋白信号提供了新的治疗策略,用于缺血性心脏病。